Detalhe da pesquisa
1.
Shortened 8 Weeks Course of Dual Sofosbuvir/Daclatasvir Therapy in Adolescent Patients, With Chronic Hepatitis C Infection.
J Pediatr Gastroenterol Nutr
; 66(3): 425-427, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29135824
2.
Dual Sofosbuvir/Daclatasvir Therapy in Adolescent Patients With Chronic Hepatitis C Infection.
J Pediatr Gastroenterol Nutr
; 67(1): 86-89, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29570560
3.
Effects of Dual Sofosbuvir/Daclatasvir Therapy on Weight and Linear Growth in Adolescent Patients with Chronic Hepatitis C Virus Infection.
Pediatr Infect Dis J
; 38(7): e154-e157, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31194713